We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

TRI:TSXThomson Reuters Corporation Analysis

Data as of 2026-03-13 - not real-time

CA$132.40

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

Thomson Reuters (TRI) is trading at CAD 132.4, just above its 20‑day SMA of 132.1 but well below the 50‑day (146.9) and 200‑day (211.0) averages, signalling a bearish medium‑term trend. The RSI sits at 44, indicating neutral momentum, while the MACD histogram is positive and the signal line is bullish, offering a modest technical upside. Volatility is exceptionally high at 81% over the past 30 days and trading volume is decreasing, which adds short‑term risk. Fundamentally, the company delivers solid profitability (20% profit margin, 26% operating margin) and strong cash generation (free cash flow > CAD 1.6 bn), supporting its 2.63% dividend yield, though a 72% payout ratio pushes sustainability limits. The DCF fair value of CAD 58.4 is far below the current price, implying the stock is overvalued despite analyst consensus (Buy) and an upside potential of roughly 40% based on target prices. Recent material news – a $600 million share‑repurchase program, a $605 million return‑of‑capital plan, and a CFO transition – could provide near‑term price support but also introduce execution risk.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Bearish technical positioning (price below SMA50/200)
  • High 30‑day volatility and decreasing volume
  • Upcoming share‑repurchase may provide temporary support

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • Strong cash flow and dividend yield
  • Analyst consensus (Buy) with median target ~CAD 173
  • Share‑repurchase and return‑of‑capital plan boosting EPS

Long Term

> 3 years
Neutral
Model confidence: 7/10

Key Factors

  • Sustainable dividend and solid profitability
  • Overvaluation relative to DCF fair value
  • Diversified global revenue mitigating single‑region risk

Key Metrics & Analysis

Financial Health

Revenue Growth5.20%
Profit Margin20.09%
P/E Ratio29.6
ROE12.40%
ROA6.68%
Debt/Equity20.04
P/B Ratio3.7
Op. Cash FlowCA$2.7B
Free Cash FlowCA$1.6B
Industry P/E29.2

Technical Analysis

TrendBearish
RSI44.3
SupportCA$109.20
ResistanceCA$153.83
MA 20CA$132.11
MA 50CA$146.92
MA 200CA$211.03
MACDBullish
VolumeDecreasing
Fear & Greed Index73.18

Valuation

Fair ValueCA$58.38
Target PriceCA$185.36
Upside/Downside40.00%
GradeOvervalued
TypeBlend
Dividend Yield2.63%

Risk Assessment

Beta0.47
Volatility81.01%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.